OMEGA HEALTHCARE INVESTORS INC 8K

Omega Healthcare Investors, Inc. announced strong Q2 2026 results with higher earnings and AFFO, significant investment and disposition activity, a dividend increase, a new segment reporting structure, and an upward revision to 2026 Adjusted FFO guidance.

On July 29, 2026, Omega Healthcare Investors, Inc. reported strong financial results for the quarter ended June 30, 2026, highlighted by a substantial increase in net income to $380 million, higher Adjusted FFO and FAD, completion of $126 million in new Q2 investments and $93 million of July 2026 investments, and the sale of 26 facilities for $563 million including 18 CommuniCare properties, along with an expansion of its relationship with Saber Healthcare through the Saber PropCo JV and the transition of 27 facilities into Saber’s operating platform. The company also announced a $0.01 increase in its quarterly dividend to $0.68 per share effective August 3, 2026, a move to two reportable segments (Triple-Net Investments and Operating Portfolio), and an increase to full-year 2026 Adjusted FFO guidance to a range of $3.22–$3.26 per diluted share, based on assumptions including continued full rent payments from Genesis and Maplewood, expected loan repayments and modest ongoing asset sales. Management commentary emphasized the favorable operating environment, the accretive nature of recent capital deployment including its first U.K. care home operating company acquisition and Canadian development financing, and the expectation of materially higher capital allocation over the remainder of 2026 and into early 2027, while also noting leadership transition-related severance and stock-based compensation charges tied to the CEO’s planned retirement.

Filing Facts

CIK

888491

Ticker

-

Form

8K

Source Type

sec

Accession

0000888491-26-000022

Alert Tier

7